WCRI explores how drug payments varied across 28 states for key drug therapy groups.
WCRI explores how drug payments varied across 28 states for key drug therapy groups.
State-led efforts to combat the drug price issue continue to emerge across the nation.
Data from 28 states years found that NSAIDs and dermatological agents are seeing growth in spending.
Federal lawmakers and administrative agencies continue to investigate how to best lower ever-increasing drug prices.
As 2018’s legislative trends continue to spill into 2019, what big initiatives might impact workers’ comp this year?
